238 related articles for article (PubMed ID: 31189769)
21. "Micromegaly": an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era.
Butz LB; Sullivan SE; Chandler WF; Barkan AL
Pituitary; 2016 Dec; 19(6):547-551. PubMed ID: 27497970
[TBL] [Abstract][Full Text] [Related]
22. Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease.
Dreijerink KM; van Beek AP; Lentjes EG; Post JG; van der Luijt RB; Canninga-van Dijk MR; Lips CJ
Eur J Endocrinol; 2005 Dec; 153(6):741-6. PubMed ID: 16322378
[TBL] [Abstract][Full Text] [Related]
23. Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up.
Lv L; Jiang Y; Yin S; Hu Y; Chen C; Ma W; Jiang S; Zhou P
Endocrine; 2019 Nov; 66(2):310-318. PubMed ID: 31368083
[TBL] [Abstract][Full Text] [Related]
24. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features.
Shintani Y; Yoshimoto K; Horie H; Sano T; Kanesaki Y; Hosoi E; Yokogoshi Y; Bando H; Iwahana H; Kannuki S
Endocr J; 1995 Jun; 42(3):331-40. PubMed ID: 7670561
[TBL] [Abstract][Full Text] [Related]
25. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
[TBL] [Abstract][Full Text] [Related]
26. Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report.
Brock P; Bustamante Alvarez J; Mortazavi A; Roychowdhury S; Phay J; Khawaja RA; Shah MH; Konda B
Fam Cancer; 2020 Apr; 19(2):189-192. PubMed ID: 32052251
[TBL] [Abstract][Full Text] [Related]
27. A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma.
Sato M; Miyauchi A; Namihira H; Bhuiyan MM; Imachi H; Murao K; Takahara J
Endocrine; 2000 Jun; 12(3):223-6. PubMed ID: 10963041
[TBL] [Abstract][Full Text] [Related]
28. Neurofibromatosis Type 1 Has a Wide Spectrum of Growth Hormone Excess.
Hannah-Shmouni F; Trivellin G; Beckers P; Karaviti LP; Lodish M; Tatsi C; Adesina AM; Adamidou F; Mintziori G; Josefson JL; Quezado M; Stratakis CA
J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456261
[TBL] [Abstract][Full Text] [Related]
29. Impact of preoperative pasireotide therapy on invasive octreotide-resistant acromegaly.
Yamamoto R; Robert Shima K; Igawa H; Kaikoi Y; Sasagawa Y; Hayashi Y; Inoshita N; Fukuoka H; Takahashi Y; Takamura T
Endocr J; 2018 Oct; 65(10):1061-1067. PubMed ID: 30078825
[TBL] [Abstract][Full Text] [Related]
30. Poorly-controlled acromegaly accompanied by subclinical adrenal Cushing's syndrome after surgery for multiple endocrine tumors.
Ishikawa M; Kato M; Sasaki H; Morii T; Fujita H; Kakei M; Narita T; Yamada Y
Intern Med; 2015; 54(6):617-20. PubMed ID: 25786452
[TBL] [Abstract][Full Text] [Related]
31. Duodenal adenocarcinoma with neuroendocrine features in a patient with acromegaly and thyroid papillary adenocarcinoma: a unique combination of endocrine neoplasia.
Kato K; Takeshita Y; Misu H; Ishikura K; Kakinoki K; Sawada-Kitamura S; Kaneko S; Takamura T
Endocr J; 2012; 59(9):791-6. PubMed ID: 22673565
[TBL] [Abstract][Full Text] [Related]
32. Neurofibromatosis type 1 and primary hyperparathyroidism with spinal deformity and osteoporosis.
Bahadir C; Gürleyik G; Ocak E
Acta Chir Belg; 2009; 109(1):123-5. PubMed ID: 19341215
[TBL] [Abstract][Full Text] [Related]
33. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
[TBL] [Abstract][Full Text] [Related]
34. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
35. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
[TBL] [Abstract][Full Text] [Related]
36. A novel germline mutation of MEN 1 gene in a patient with acromegaly and multiple endocrine tumors.
Pinna G; Orgiana G; Carcassi C; Alba F; Cetani F; Pardi E; Marcocci C; Mariotti S
J Endocrinol Invest; 2004 Jun; 27(6):577-82. PubMed ID: 15717658
[TBL] [Abstract][Full Text] [Related]
37. Mixed pituitary adenoma and gangliocytoma associated with acromegaly--case report.
Asada H; Otani M; Furuhata S; Inoue H; Toya S; Ogawa Y
Neurol Med Chir (Tokyo); 1990 Aug; 30(8):628-32. PubMed ID: 1703643
[TBL] [Abstract][Full Text] [Related]
38. [Acromegaly--do we already know everything about treatment of the somatotroph pituitary adenomas?].
Zieliński G; Podgórski JK
Przegl Lek; 2002; 59(7):540-7. PubMed ID: 12516247
[TBL] [Abstract][Full Text] [Related]
39. A somatotropin-producing pituitary adenoma with an isolated adrenocorticotropin-producing pituitary adenoma in a female patient with acromegaly, subclinical Cushing's disease and a left adrenal tumor.
Kobayashi Y; Takei M; Ohkubo Y; Kakizawa Y; Matoba H; Kumagai M; Takeda T; Suzuki S; Komatsu M
Endocr J; 2014; 61(6):589-95. PubMed ID: 24705560
[TBL] [Abstract][Full Text] [Related]
40. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
